PTGS2 and neoplasm: When studied in vitro, inhibition of both PDK1 and SERCA requires substantially higher drug concentrations than are necessary to inhibit either COX-2 or CAs; nonetheless, recent evidence obtained from the use of animal tumour models demonstrates that PDK-1 and SERCA are also affected by celecoxib in vivo (see below).